|
|
|
Insider
Information: |
Szyman Catherine M |
Relationship: |
Director |
City: |
Minneapolis |
State: |
MN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
123,190 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,324,616 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
123,190 |
|
|
Total
Value |
$2,324,616 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
52.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP, Critical Care |
2024-05-11 |
76,165 |
2019-08-30 |
0 |
Premium* |
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
22,429 |
2020-05-27 |
0 |
Premium* |
|
Outset Medical, Inc. |
OM |
Director |
2023-05-31 |
24,596 |
2021-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NARI |
Inari Medical, Inc. |
|
|
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,380 |
29,471 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-02-19 |
4 |
D |
$177.78 |
$519,829 |
D/D |
(2,924) |
23,747 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-02-21 |
4 |
AS |
$176.34 |
$57,840 |
I/I |
(328) |
2,302 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-02-21 |
4 |
AS |
$176.34 |
$202,086 |
D/D |
(1,146) |
22,601 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-03-15 |
4 |
AS |
$179.10 |
$58,745 |
I/I |
(328) |
1,974 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-03-15 |
4 |
AS |
$179.10 |
$205,249 |
D/D |
(1,146) |
21,455 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-04-15 |
4 |
AS |
$192.00 |
$220,032 |
D/D |
(1,146) |
20,358 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-04-15 |
4 |
AS |
$192.00 |
$62,976 |
I/I |
(328) |
1,646 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,850 |
22,208 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,595 |
24,803 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-05-12 |
4 |
D |
$181.10 |
$356,586 |
D/D |
(1,969) |
22,834 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-05-14 |
4 |
D |
$178.17 |
$189,929 |
D/D |
(1,066) |
21,768 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-06-14 |
4 |
AS |
$184.55 |
$211,494 |
D/D |
(1,146) |
19,476 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-06-14 |
4 |
AS |
$184.55 |
$60,532 |
I/I |
(328) |
990 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-07-15 |
4 |
AS |
$191.70 |
$62,878 |
I/I |
(328) |
662 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-07-15 |
4 |
AS |
$191.70 |
$220,838 |
D/D |
(1,152) |
18,382 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-08-15 |
4 |
AS |
$214.53 |
$79,805 |
D/D |
(372) |
18,010 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-08-15 |
4 |
AS |
$214.53 |
$70,366 |
I/I |
(328) |
334 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-08-30 |
4 |
AS |
$222.00 |
$82,584 |
D/D |
(372) |
17,638 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-08-30 |
4 |
AS |
$222.00 |
$74,148 |
I/I |
(334) |
0 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-09-19 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
20,138 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-09-19 |
4 |
AS |
$216.71 |
$541,775 |
D/D |
(2,500) |
17,638 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-09-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
583 |
17,055 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-10-25 |
4 |
OE |
$66.86 |
$167,150 |
D/D |
2,500 |
19,605 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-10-25 |
4 |
AS |
$227.19 |
$567,975 |
D/D |
(2,500) |
17,105 |
0 |
- |
|
157 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|